1-Ethoxy-3-Propoxybenzene

1-Ethoxy-3-Propoxybenzene

SCHEMBL3459404

CCCOc1cccc(OCC)c1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C19 P33261 1/20 0.59
TP53 P04637 1/20 0.59
CYP3A4 P08684 1/20 0.59
KMT2A Q03164 2/20 0.58
ALDH1A1 P00352 3/20 0.54
LMNA P02545 3/20 0.54
TSHR P16473 3/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
KDM4E B2RXH2 5/20 0.53
HTT P42858 2/20 0.53
MAPT P10636 3/20 0.51
GPBAR1 Q8TDU6 1/20 0.51
CYSLTR1 Q9Y271 1/20 0.51
MEN1 O00255 1/20 0.51
RECQL P46063 1/20 0.51
NPSR1 Q6W5P4 1/20 0.50
NQO1 P15559 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,3-Dipropoxybenzene SCHEMBL73716 0.93 KMT2A (0.63) MAPK1CYP1A2CYP2D6CYP2C19TP53
1-Butyloxy-3-Ethoxybenzene SCHEMBL3459049 0.89 MAPK1 (0.62) MAPK1CYP1A2CYP2D6CYP2C19TP53
1,3-Diethoxybenzene SCHEMBL1100167 0.89 TP53 (0.71) MAPK1CYP1A2CYP2D6CYP2C19TP53
SCHEMBL9487763 0.87 KMT2A (0.58) MAPK1CYP1A2CYP2D6CYP2C19KMT2A
1-Butyloxy-3-Propoxybenzene SCHEMBL3390925 0.87 TSHR (0.59) MAPK1CYP1A2CYP2D6CYP2C19KMT2A
1-Hydroxy-3-Propoxybenzene SCHEMBL7605942 0.87 CHRNB2 (0.60) MAPK1CYP1A2CYP2D6CYP2C19TP53
SCHEMBL10027326 0.86 NQO1 (0.50) MAPK1CYP1A2CYP2D6CYP2C19TP53
SCHEMBL15923791 0.86 TSHR (0.69) MAPK1CYP1A2CYP2D6CYP2C19TP53
1-Butyloxy-3-Ethoxybenzene SCHEMBL27446094 0.86 MAPK1 (0.58) MAPK1CYP1A2CYP2D6CYP2C19TP53
1-Ethoxy-3-Pentoxybenzene SCHEMBL3967143 0.86 TSHR (0.64) MAPK1CYP1A2CYP2D6CYP2C19TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188216-B2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery TRANZYME PHARMA INC. (CA) 2012-05-29 US disclosed
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar SIMON FRASER UNIVERSITY (CA) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar L3MBTL3, L3MBTL4, L3MBTL1 MAPK1 4550/4885CYP1A2 2220/4885CYP2D6 2962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.